Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Eradicating hepatitis B virus: The critical role of preventing perinatal transmission.

Stevens CE, Toy P, Kamili S, Taylor PE, Tong MJ, Xia GL, Vyas GN.

Biologicals. 2017 Nov;50:3-19. doi: 10.1016/j.biologicals.2017.08.008. Epub 2017 Sep 2. Review.

2.

Remembering James W. Mosley, MD (1929-2015), and his legacy in transfusion safety.

Busch MP, Vyas GN.

Transfusion. 2016 Apr;56(4):996-8. doi: 10.1111/trf.13570. No abstract available.

PMID:
27079314
3.
4.

Adverse effects of plasma transfusion.

Pandey S, Vyas GN.

Transfusion. 2012 May;52 Suppl 1:65S-79S. doi: 10.1111/j.1537-2995.2012.03663.x. Review.

5.

The life and legacy of Alfred M. Prince, M. D. (1928-2011).

Vyas GN, Grady GF.

Biologicals. 2012 Jan;40(1):1-2. No abstract available.

PMID:
22408790
6.

Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies.

Vyas GN, Stoddart CA, Killian MS, Brennan TV, Goldberg T, Ziman A, Bryson Y.

Biologicals. 2012 Jan;40(1):15-20. doi: 10.1016/j.biologicals.2011.11.005. Epub 2011 Dec 20.

7.

Unconventional journals: research ramifications.

Vyas GN.

Science. 2010 Apr 23;328(5977):427. doi: 10.1126/science.328.5977.427-a. No abstract available.

PMID:
20413475
8.

Preparation and use of therapeutic antibodies primarily of human origin.

Stiehm ER, Keller MA, Vyas GN.

Biologicals. 2008 Nov;36(6):363-74. doi: 10.1016/j.biologicals.2008.07.002. Epub 2008 Sep 11. Review.

PMID:
18789721
9.

Participating in the evolution of transfusion medicine from a dispensary into a discipline.

Vyas GN.

Transfus Med Rev. 2008 Apr;22(2):162-7. doi: 10.1016/j.tmrv.2007.12.005.

10.

Blood-transmitted prions and variant Creutzfeldt-Jakob disease.

Grady GF, Vyas GN.

Biologicals. 2007 Apr;35(2):75-7. Epub 2007 Feb 20. No abstract available.

PMID:
17317213
11.

Human peripheral blood mononuclear cell substrate for propagating wild type HIV-1.

Vyas GN.

Dev Biol (Basel). 2001;106:345-56; discussion 356-7.

PMID:
11761248
12.
13.

Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).

Gandhi MJ, Boyd MR, Yi L, Yang GG, Vyas GN.

Dev Biol (Basel). 2000;102:141-8. Review.

PMID:
10794101
14.

Immunobiology of persistent blood-borne viral infections.

Vyas GN.

Dev Biol (Basel). 2000;102:9-17. Review.

PMID:
10794086
15.

A prospective study of the risk of transfusion-acquired viral infections.

Murphy EL, Busch MP, Tong M, Cornett P, Vyas GN.

Transfus Med. 1998 Sep;8(3):173-8.

PMID:
9800288
16.
17.

Transmission of HIV-1 in infants born to seropositive mothers: PCR-amplified proviral DNA detected by flow cytometric analysis of immunoreactive beads.

Dorenbaum A, Venkateswaran KS, Yang G, Comeau AM, Wara D, Vyas GN.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1;15(1):35-42.

PMID:
9215652
18.

Editor's Note.

Vyas GN, Gelb AB, Venkateswaran KS.

Biologicals. 1996 Sep;24(3):147-148.

PMID:
9837682
19.

Editorial summary of the Pre-symposium workshop on the Contemporary Assessment of Technologies.

Gelb AB, Venkateswaran KS, Vyas GN.

Biologicals. 1996 Sep;24(3):177-86.

PMID:
8978914
21.

Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Yang G, Vyas GN.

Clin Diagn Lab Immunol. 1996 May;3(3):247-56. Review. No abstract available.

22.

The risk of HIV transmission by screened blood.

Vyas GN, Rawal BD.

N Engl J Med. 1996 Apr 11;334(15):992; author reply 993. No abstract available.

PMID:
8596612
23.
25.

Inactivation and removal of blood-borne viruses.

Vyas GN.

Transfusion. 1995 May;35(5):367-70. No abstract available.

PMID:
7740604
26.

DNA enzyme immunoassay of the PCR-amplified HLA-DQ alpha gene for estimating residual leukocytes in filtered blood.

Prati D, Rawal BD, Dang C, Capelli C, Vyas GN.

Clin Diagn Lab Immunol. 1995 Mar;2(2):182-5.

27.

In vitro inactivation of human immunodeficiency virus by ascorbic acid.

Rawal BD, Bartolini F, Vyas GN.

Biologicals. 1995 Mar;23(1):75-81.

PMID:
7619441
28.
29.

Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.

Sankary TM, Yang G, Romeo JM, Ulrich PP, Busch MP, Rawal BD, Vyas GN.

Transfusion. 1994 Aug;34(8):656-60.

PMID:
8073480
30.

Complement killing of Yersinia enterocolitica and retention of the bacteria by leucocyte removal filters.

Gong J, Rawal BD, Högman CF, Vyas GN, Nilsson B, Gustafsson I.

Vox Sang. 1994;66(3):166-70.

PMID:
8036784
31.
32.

Detection of exceedingly low levels of HIV proviral DNA in multimillion peripheral blood mononuclear cells by PCR.

Babu PG, Rawal BD, Khayam-Bashi H, Vyas GN.

PCR Methods Appl. 1993 Aug;3(1):63-4. No abstract available.

33.

Complement-mediated bactericidal action and the removal of Yersinia enterocolitica by white cell filters.

Rawal BD, Vyas GN.

Transfusion. 1993 Jun;33(6):536. No abstract available.

PMID:
8516801
34.
36.
37.
39.

Hepatitis C virus detection in blood donors.

Romeo JM, Ulrich PP, Vyas GN.

Transfusion. 1991 Oct;31(8):780. No abstract available.

PMID:
1656554
40.

Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells.

Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, Sninsky J, Perkins HA, Vyas GN.

N Engl J Med. 1991 Jul 4;325(1):1-5.

41.

Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women.

Weintrub PS, Ulrich PP, Edwards JR, Boucher F, Levy JA, Cowan MJ, Vyas GN.

AIDS. 1991 Jul;5(7):881-4.

PMID:
1892594
42.
43.

Mutations in the S-gene affecting the immunologic determinants of the envelope protein of hepatitis B virus.

Lee HS, Ulrich PP, Vyas GN.

J Hepatol. 1991;13 Suppl 4:S97-101. Review. No abstract available.

PMID:
1726591
44.

Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification.

Rawal BD, Schwadron R, Busch MP, Endow R, Vyas GN.

Blood. 1990 Nov 15;76(10):2159-61.

45.
46.

[Effective use of hepatitis tests].

Vyas GN.

Taehan Kanho. 1990 Oct 31;29(4):38-43. Korean. No abstract available.

PMID:
2125092
47.

A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease.

Ulrich PP, Bhat RA, Kelly I, Brunetto MR, Bonino F, Vyas GN.

J Med Virol. 1990 Oct;32(2):109-18.

PMID:
2280256
48.

Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection.

Rawal BD, Davis RE, Busch MP, Vyas GN.

Transfus Med Rev. 1990 Oct;4(4 Suppl 1):36-41. Review. No abstract available.

PMID:
2134639
49.
50.

Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infection.

Roy S, Morrow WJ, Christian C, Khayam-Bashi H, Busch MP, McCarthy R, Rodgers RP, Vyas GN.

J Acquir Immune Defic Syndr. 1990;3(2):134-8.

PMID:
1967308

Supplemental Content

Support Center